North America Variant Identified in Amish Population Appears to Protect From Cardiovascular Disease A rare missense variant in the enzyme-coding gene B4GALT1 is linked to lower coronary artery disease risk and reduced blood LDL cholesterol levels. Danaher Prices $1B Offering of Senior Notes Net proceeds from the offering are expected to be $984 million, which Danaher plans to use to redeem all outstanding 2.5 percent senior notes due in 2025. Discovery Life Sciences Acquires Contract Research Firm In Vitro ADMET Laboratories Maryland-based IVAL offers physiologically relevant in vitro experimental systems for drug metabolism, toxicology, and pharmacology testing. Audere Gets FDA Emergency Use Authorization for SARS-CoV-2 At-Home Sample Collection Kit The kit, developed by digital health firm Audere, is designed for the collection of anterior nasal swab specimens for molecular COVID-19 testing in children and adults. Labs Home in on SARS-CoV-2 Omicron Variant Premium The Association of Public Health Laboratories is directing member labs to focus sequencing efforts on S-gene dropouts for the next week. Dec 1, 2021 Sense Biodetection Gearing up to Debut Instrument-Free Point-of-Care MDx Premium Dec 1, 2021 GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Dec 1, 2021 Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy Dec 1, 2021 Metabolomic Study Links 13 Metabolites to Coronary Heart Disease Risk Among African Americans Dec 1, 2021 Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests Dec 1, 2021 Freenome, Siemens Healthineers Partner to ID Blood-Based Breast Cancer Biomarkers Nov 30, 2021 InnoTech, MIT Developing Multiplexed Biosensor Platform for SARS-CoV-2 Testing Premium Nov 30, 2021 Immunexpress Receives FDA 510(k) Clearance for Sepsis Assay Nov 30, 2021 Exact Sciences, Pfizer End Cologuard Copromotion Agreement Nov 30, 2021 BioMark Diagnostics, AstraZeneca, Pfizer, Others Partner in Lung Cancer Screening Project Nov 30, 2021 Akoya Receives CLIA Certification for Biopharma Solutions Laboratory Nov 29, 2021 GE Healthcare, University of Cambridge Team on AI-Based Precision Oncology Nov 29, 2021 Qiagen Sued for Allegedly Infringing Patent With Wi-Fi-Connected Instrument Nov 29, 2021 Oppenheimer, BTIG Initiate Coverage of MDxHealth at Outperform, Buy Nov 24, 2021 IndyGeneUS AI Acquires Genetic Cryptocurrency Creator EncrypGen Nov 24, 2021 HER2 Treatments See New Milestones in Colorectal Cancer, With Liquid Biopsy Identifying Responders Premium Nov 24, 2021 Local Cancer Genomic Profiling Options Grow, Though Central Labs Will Likely Keep Major Role Premium Nov 24, 2021 Streamline Genomics Looks to Expand Variant Analysis Offering With Free Search, Paid Analytics Premium Nov 24, 2021 StageZero Raising C$4.2M in Private Placement of Stocks, Warrants Nov 23, 2021 Gencove Expands Low-Coverage Sequencing Business to Ag-Bio Market Premium Load More Breaking News Variant Identified in Amish Population Appears to Protect From Cardiovascular Disease Danaher Prices $1B Offering of Senior Notes Discovery Life Sciences Acquires Contract Research Firm In Vitro ADMET Laboratories Audere Gets FDA Emergency Use Authorization for SARS-CoV-2 At-Home Sample Collection Kit GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy The Scan Science Confidence Boost The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic. Appeal and Funds Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports. Surveillance for Variants Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance. Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome In Nature this week: plant genome sequencing dominated by affluent countries, and more.